Medical tools
Use these tools to better understand your starting point, explore treatment pathways, and prepare for a provider-led medical weight loss plan.
GLP-1 dosage calculator
This educational tool shows common titration patterns for select semaglutide and tirzepatide products. It is designed to help you understand how gradual dose escalation usually works before beginning a medical weight loss program. If you are still deciding whether medication-based care may be a fit, start with our GLP-1 eligibility tool or review our GLP-1 treatment page.
This page does not prescribe treatment, replace clinician judgment, or tell you what dose you should personally take.
Weight loss
A weekly semaglutide option commonly used for chronic weight management with gradual dose escalation.
This tool is educational only and does not determine whether Wegovy is appropriate for you. Final prescribing decisions, dose changes, and titration timing should be made by a licensed clinician.
Selected product
Weeks 1–4
0.25 mg once weekly
Weeks 5–8
0.5 mg once weekly
Flexible titration: Dose escalation may be delayed based on tolerability.
Weeks 9–12
1 mg once weekly
Flexible titration: Some patients remain at this dose longer depending on response and side effects.
Weeks 13–16
1.7 mg once weekly
Maintenance
2.4 mg once weekly
Flexible titration: Some patients may remain at a lower maintenance dose based on tolerability and provider guidance.
Maintenance overview
Typical maintenance is 2.4 mg once weekly.
Want broader treatment context? Compare this dosing view with our GLP-1 eligibility tool and our GLP-1 treatment overview.
Important context
Gradual dose escalation helps many patients tolerate treatment more comfortably. Clinicians often adjust timing based on how a patient is responding, whether side effects are present, and the overall treatment goal.
This is one reason a provider-led approach matters. A structured medical weight loss program can help determine whether a medication is appropriate, whether escalation should pause, and when a lower maintenance dose may make more sense.
Patients across Maine — including Windham, Portland, and nearby communities — can access care through a telehealth-first model. If you are comparing medication options, it may also help to review our BMI calculator before taking the next step.
Frequently asked questions
No. This page is educational only. It shows common dose-escalation patterns, but a licensed clinician should decide whether a medication is appropriate, when to increase a dose, and whether to pause or adjust treatment.
These medications are often started at lower doses and increased over time to improve tolerability and reduce the risk of side effects such as nausea, vomiting, or GI discomfort.
Do not use this page as a substitute for medical advice. If you miss a dose or are having side effects, contact your prescribing clinician for guidance specific to your medication and treatment plan.
Related resources
Use these pages to move from general dose education into treatment fit, eligibility, and provider-guided care options.
Review whether BMI, health history, and treatment goals may make medication-based care worth discussing with a provider.
Learn how Atlantic Health Co. approaches semaglutide and tirzepatide treatment within a provider-led medical program.
See how medication decisions, follow-up, and long-term support fit into the broader treatment plan.